An editorial in the Cochrane Library from the last week argues that clinical trial information from regulators should be included in systematic reviews of treatments. In 2014, the authors of … Continue Reading Should regulatory data from the EMA and the FDA be included in systematic reviews?
A new report, written by Nordic clinical trial experts, sets a high international standard for clinical trial transparency and sets out how to make it a reality. The report from … Continue Reading Nordic researchers want to lead the world in clinical trial transparency
What exactly is a Digital Object Identifier (DOI) and how does it help in the management and long-term preservation of research? A blog by The London School of Economics and … Continue Reading Digital Object Identifiers: stability for citations and referencing, but not proxies for quality
Recently, COPE held a seminar on metrics and how they shape publication (mis)behavior. A blog published in the past few days by BioMed Central (and written by Elizabeth Moylan) provides … Continue Reading Are metrics meaningful? A blog from BioMed Central (@biomedcentral)
An educational afternoon meeting will be held at Alderley Park in Cheshire on the 3rd of June, entitled: “An update: Publications in Practice”. The programme for this meeting is now … Continue Reading Free educational meeting on medical publications in Cheshire, UK on 3rd June
In a blog today, Iain Hrynaszkiewicz – the Head of Data and HSS Publishing at Nature Publishing Group and Palgrave Macmillan – provides a publisher’s views on improving the reproducibility … Continue Reading The role of openness and publishers in reproducible research
In an article in Trials this week, investigators from the Medical Research Council (MRC) Clinical Trials Unit at the University College London (UCL) provide an overview of their experiences of … Continue Reading Considerations relating to sharing data from clinical trials
The World Health Organization (WHO) today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result. The move aims to ensure … Continue Reading WHO announces new statement on public reporting of clinical trial results
An article published in this week’s Trials argues that it is time to design a new model of research publication, with modern technology embedded at its heart. The abstract of … Continue Reading Is it time for the research article to evolve?
Salary surveys from the American Medical Writers Association (AMWA) have served as useful sources of information for employers of medical communicators to set salary ranges and for employees and freelances/independent … Continue Reading Now running: 2015 salary survey from the American Medical Writers Association (AMWA)
Science and medicine have a ‘publication pollution’ problem, according to newly published commentary
The scientific community is facing a ‘pollution problem’ in academic publishing, and one that poses a serious threat to the “trustworthiness, utility, and value of science and medicine”, according to … Continue Reading Science and medicine have a ‘publication pollution’ problem, according to newly published commentary
Should peer reviewers receive training? Should there be accreditation? These topics and more were discussed at a recent BioMed Central roadshow in Sydney, Australia. One of the attendees, at this … Continue Reading Peer review: are early career researchers thrown in at the deep end?
How should scientists think about papers that have undergone what appears to be a cursory peer review? Perhaps the papers were reviewed in a day — or less — or … Continue Reading What to do when peer review feels inadequate?
BioMed Central roadshow in London: “Making open access work for you: publishing, peer review and innovation”
BioMed Central the open access publisher Global Roadshow will be in London on Wednesday 20th May 2015. This FREE to attend one day event will take place at the Kingsway Hall Hotel giving delegates … Continue Reading BioMed Central roadshow in London: “Making open access work for you: publishing, peer review and innovation”
The Washington Post announced recently (Friday, March 27), that BioMed Central has retracted 43 scientific papers due to concerns about fake peer review. According to the article, this is evidently … Continue Reading Major publisher retracts 43 scientific papers amid wider fake peer-review scandal